Many object to embryo selection because they mistakenly believe it involves altering genes. In reality, the technology simply reveals information about natural genetic variations already present in IVF embryos, allowing parents to choose, not tinker.

Up to 40% of natural conceptions are spontaneously aborted, often before a woman knows she's pregnant. This is typically the body's way of rejecting embryos with severe genetic abnormalities. This natural process provides a powerful biological precedent for the practice of pre-implantation genetic screening.

Government subsidies for genetic screening could solve the problem of genetic inequality. However, this policy forces citizens who morally or religiously object to the technology to fund it through their taxes, creating a fundamental conflict between promoting equality and respecting individual liberty and conscience.

In the U.S., support for embryo screening for disease is nearly double that for intelligence, while in Singapore, support is equal. This gap is attributed to Western taboos from WWII-era eugenics, creating a moral distinction between selecting against negative traits and for positive ones that is less pronounced elsewhere.

An internal Nucleus Genomics experiment revealed that when 16 employees chose from 8 embryos, there were 14 unique selections. This demonstrates that 'optimization' is based on highly personal values, countering the fear that genetic selection will lead to a human monoculture.

Ideologies that rely on a 'blank slate' view of human nature have made a catastrophic error. As genetic technologies become mainstream, the public is forced to confront the tangible reality of genetic predispositions in their own reproductive choices. This will unravel the blank slate worldview, a cornerstone of some progressive thought.

Standard IVF practice involves a doctor visually selecting the embryo that appears most "normally shaped." This is already a form of selection. Polygenic screening simply replaces this subjective "eyeballing" method with quantitative genetic data for a more informed choice, making it an evolution, not a revolution.

Fears that embryo selection will create a uniform human population are misplaced. The process is a *relative* optimization, limited to the genetic diversity provided by the two parents. The choice of partner has a far more significant impact on the gene pool than selecting among resulting embryos.

Polygenic embryo screening, while controversial, presents a clear economic value proposition. A $3,500 test from Genomic Prediction that lowers Type 2 Diabetes risk by 12% implies that avoiding the disease is worth over $27,000. This reframes the service from 'designer babies' to a rational financial decision for parents.